Related Experiment Videos
Putative functional characteristics of human estrogen receptor-beta isoforms
1Department of Biochemistry and Medical Genetics and the Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada R3E 0V9.
Journal of Molecular Endocrinology
|February 13, 2003
Summary
Human estrogen receptor beta (ERbeta) isoforms have distinct functions in breast tissue. ERbeta1 binds ligands and bends DNA, while all ERbeta isoforms inhibit ERalpha activity, suggesting a role in modulating estrogen action.
Area of Science:
- Molecular Endocrinology
- Genetics
- Biochemistry
Background:
- Estrogen receptors (ERalpha and ERbeta) exhibit complex structures and functions.
- Multiple ERbeta isoforms exist and are expressed differently across tissues.
- Understanding ERbeta's role in breast tissue is crucial for estrogen-related gene expression.
Purpose of the Study:
- To investigate the functions of human ERbeta1, ERbeta2, and ERbeta5 isoforms in breast tissue.
- To elucidate the differential activities of ERbeta isoforms on ERalpha-regulated gene expression.
- To determine the promoter-specific effects of ERbeta isoforms on estrogen action.
Main Methods:
- Ligand binding assays and protease digestion to assess conformational changes.
- DNA binding and bending assays to compare ERbeta isoform efficiencies.
- Reporter gene assays (ERE-CAT and TGF-beta3-CAT) to evaluate transcriptional activity.
Main Results:
- Only ERbeta1 bound ligand, inducing conformational changes.
- All ERbeta isoforms bound and bent DNA with varying efficiencies (ERalpha > ERbeta1 > ERbeta2 >> ERbeta5).
- ERbeta isoforms inhibited ERalpha transcriptional activity on an ERE-reporter gene, with ERbeta1 > ERbeta2 > ERbeta5.
- ERbeta1 exhibited its own transcriptional activity, while ERbeta2 and ERbeta5 inhibited ERalpha activity on a TGF-beta3-CAT gene.
Conclusions:
- Human ERbeta isoforms display promoter-specific differential activities.
- ERbeta isoforms differentially modulate ERalpha-regulated gene expression.
- These findings suggest a significant role for ERbeta isoforms in fine-tuning estrogen signaling in breast tissue.